Detail akcie West Pharm Svc online

Business Summary: West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, West Pharmaceutical Services Inc revenues increased 6% to $3.07B. Net income increased less than 1% to $493.7M. Revenues reflect Proprietary Products segment increase of 7% to $2.49B, Contract-Manufactured Products segment increase of 4% to $582M, United States segment increase of 8% to $1.33B, Other European Countries segment increase of 17% to $451M, Other segment increase of 4% to $353.3M.